Pharmaceutical Suppositories Market (By Type: Rectal Suppositories, Vaginal Suppositories, and Urethral Suppositories; By Base: Fatty Bases, Water Miscible Base, and Emulsifying Bases; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Sales; By End-User: Hospitals & Clinics, Home Care, and Nursing Home) – Global Industry Analysis, Market Size, Opportunities and Forecast 2021-2028

CHAPTER 1. Industry Overview of Pharmaceutical Suppositories

1.1. Definition and Scope 

1.1.1. Definition of Pharmaceutical Suppositories

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Pharmaceutical Suppositories market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Pharmaceutical Suppositories By Type

1.2.3. Pharmaceutical Suppositories By Base

1.2.4. Pharmaceutical Suppositories By Distribution Channel

1.2.5. Pharmaceutical Suppositories By End-User

1.2.6. Pharmaceutical Suppositories by Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical Suppositories Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Pharmaceutical Suppositories Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2019

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019

4.2. R&D Status and Application Source of Pharmaceutical Suppositories Major Manufacturers in 2019

CHAPTER 5. Pharmaceutical Suppositories By Type

5.1. Introduction

5.2. Pharmaceutical Suppositories Revenue By Type

5.2.1. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast, By Type, 2017-2028

5.2.2. Rectal Suppositories

5.2.2.1. Rectal Suppositories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.3. Urethral Suppositories

5.2.3.1. Urethral Suppositories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.4. Vaginal Suppositories

5.2.4.1. Vaginal Suppositories  Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 6. Pharmaceutical Suppositories Market By Base 

6.1. Introduction

6.2. Pharmaceutical Suppositories Revenue (US$ Bn) By Base

6.2.1. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

6.2.2. Fatty Bases

6.2.2.1. Fatty Bases Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.3. Emulsifying Bases

6.2.3.1. Emulsifying Based Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.3.2. Witepsol

6.2.3.2.1. Witepsol Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.3.3. Massa Esterium

6.2.3.3.1. Massa Esterium Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.3.4. Massuppol

6.2.3.4.1. Massuppol Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.4. Water Miscible Base

6.2.4.1. Water Miscible Base Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.4.2. Glycero Gelatin Base

6.2.4.2.1. Glycero Gelatin Base Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.4.3. Soap Glycerin Suppositories

6.2.4.3.1. Soap Glycerin Suppositories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.4.4. Polyethylene Glycol Base

6.2.4.4.1. Polyethylene Glycol Base Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 7. Pharmaceutical Suppositories Market Revenue By End-User

7.1. Introduction

7.2. Pharmaceutical Suppositories Revenue (US$ Bn) By End-User

7.2.1. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

7.2.2. Hospitals & Clinics

7.2.2.1. Hospitals & Clinics Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

7.2.3. Home Care

7.2.3.1. Home Care Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

7.2.4. Nursing Home

7.2.4.1. Nursing Home Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 8. Pharmaceutical Suppositories Market By Distribution Channel 

8.1. Introduction

8.2. Pharmaceutical Suppositories Revenue (US$ Bn) By Base

8.2.1. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

8.2.2. Retail Pharmacies

8.2.2.1. Retail Pharmacies Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

8.2.3. Hospital Pharmacies

8.2.3.1. Hospital Pharmacies Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

8.2.4. Nursing Home

8.2.4.1. Nursing Home Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 9. North America Pharmaceutical Suppositories Market By Country 

9.1. North America Pharmaceutical Suppositories Overview

9.2. U.S.

9.2.1. U.S. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

9.2.2. U.S. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

9.2.3. U.S. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

9.2.4. U.S. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

9.3. Canada

9.3.1. Canada Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

9.3.2. Canada Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

9.3.3. Canada Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

9.3.4. Canada Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

9.4. North America PEST Analysis

CHAPTER 10. Europe Pharmaceutical Suppositories Market By Country

10.1. Europe Pharmaceutical Suppositories Overview

10.2. U.K.

10.2.1. U.K. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

10.2.2. U.K. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

10.2.3. U.K. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

10.2.4. U.K. Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

10.3. Germany

10.3.1. Germany Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

10.3.2. Germany Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

10.3.3. Germany Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

10.3.4. Germany Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

10.4. France 

10.4.1. France Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

10.4.2. France Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

10.4.3. France Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

10.4.4. France Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

10.5. Spain

10.5.1. Spain Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

10.5.2. Spain Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

10.5.3. Spain Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

10.5.4. Spain Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

10.6. Rest of Europe

10.6.1. Rest of Europe Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

10.6.2. Rest of Europe Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

10.6.3. Rest of Europe Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

10.6.4. Rest of Europe Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Pharmaceutical Suppositories Market By Country

11.1. Asia Pacific Pharmaceutical Suppositories Overview

11.2. China

11.2.1. China Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

11.2.2. China Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

11.2.3. China Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.2.4. China Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

11.3. Japan

11.3.1. Japan Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

11.3.2. Japan Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

11.3.3. Japan Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.3.4. Japan Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

11.4. India

11.4.1. India Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

11.4.2. India Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

11.4.3. India Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.4.4. India Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

11.5. Australia

11.5.1. Australia Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

11.5.2. Australia Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

11.5.3. Australia Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.5.4. Australia Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

11.6. South Korea

11.6.1. South Korea Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

11.6.2. South Korea Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

11.6.3. South Korea Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.6.4. South Korea Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

11.7.2. Rest of Asia-Pacific Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

11.7.3. Rest of Asia-Pacific Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.7.4. Rest of Asia-Pacific Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Pharmaceutical Suppositories Market By Country

12.1. Latin America Pharmaceutical Suppositories Overview

12.2. Brazil

12.2.1. Brazil Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

12.2.2. Brazil Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

12.2.3. Brazil Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.2.4. Brazil Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

12.3. Mexico

12.3.1. Mexico Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

12.3.2. Mexico Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

12.3.3. Mexico Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.3.4. Mexico Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

12.4. Rest of Latin America

12.4.1. Rest of Latin America Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

12.4.2. Rest of Latin America Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

12.4.3. Rest of Latin America Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.4.4. Rest of Latin America Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Pharmaceutical Suppositories Market By Country 

13.1. Middle East & Africa Pharmaceutical Suppositories Overview

13.2. GCC

13.2.1. GCC Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

13.2.2. GCC Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

13.2.3. GCC Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

13.2.4. GCC Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

13.3. South Africa

13.3.1. South Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

13.3.2. South Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

13.3.3. South Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

13.3.4. South Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Type, 2017-2028

13.4.2. Rest of Middle East & Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Base, 2017-2028

13.4.3. Rest of Middle East & Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By End-User, 2017-2028

13.4.4. Rest of Middle East & Africa Pharmaceutical Suppositories Revenue (US$ Bn) and Forecast By Distribution Channel, 2017-2028

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Pharmaceutical Suppositories

14.1. Pharmaceutical Suppositories Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Pharmaceutical Suppositories market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. COMPANY PROFILE

15.1. Bayer AG 

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (US$ Bn), 2019

15.1.3.2. Bayer AG 2019 Pharmaceutical Suppositories Business Regional Distribution

15.1.4. Product/ Service and Specification

15.1.5. Recent Developments & Business Strategy

15.1.6. Manufacturing Plant Footprint Analysis

15.2. Bliss GVS Pharma Ltd 

15.3. Cadila Healthcare Ltd

15.4. Church And Dwight Uk Ltd 

15.5. Cosette Pharmaceuticals, Inc. 

15.6. Glenmark Pharmaceuticals Limited 

15.7. Intas Pharmaceuticals Ltd. 

15.8. Novartis International Ag 

15.9. Pfizer Inc. 

15.10. Sanofi S.A.

15.11. Others